SWORD Health is a tech-enabled MSK care provider, working to make it possible for everyone to manage and overcome their pain.
SWORD has developed and tested therapeutic intervention that treats preventive, chronic and post-surgical pain in-market and clinically.
SWORD Health was founded in Portugal in 2015 by Virgilio Bento and Márcio Colunas. The company is headquartered in New York, with offices in Porto, Portugal, Chicago, Salt Lake City and Sydney.
SWORD’s personalized care is more effective and less expensive than the traditional gold standard of care, and has been third-party validated to deliver best-in-class clinical results.
SWORD recently launched SWORD+ - with three groundbreaking features. First, ASK a PT™ is a 24/7 solution connecting members with physical therapists. Second, Digital Guardian™ applies wearable and video motion capture components to monitor and correct unsafe movements. finally, The Academy which is a unique blend of Masterclass and customized educational content.
SWORD Health has worked with insurers, health systems, and employers in the U.S., Canada, Europe, and Australia to make high quality musculoskeletal care accessible to everyone.
SWORD is backed by General Catalyst, Sapphire Ventures, Khosla Ventures, BOND, Highmark Ventures, BPEA, Khosla Ventures, Founders Fund, Sozo Ventures, Willoughby Capital, and others. The company raised $163M in Series D round on Nov 22, 2021. This brings SWORD's total funding to $294.6M to date. The latest round valued the company at $2B post-money.